Osteomet
Formulation
Each 5 ml vial of concentrated solution contains:
Zoledronic acid (as monohydrate) 4 mg

Zoledronic Acid

Osteomet®

Prescription Drug

Indication

  • For the prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumor-induced hypercalcemia) in adult patients with advanced malignancies involving bone.
  • For the treatment of adult patients with tumor-induced hypercalcemia (TIH).

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.